Cibus (NASDAQ:CBUS - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.08), Zacks reports. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%.
Cibus Trading Down 8.5 %
Shares of Cibus stock traded down $0.20 on Friday, reaching $2.15. 117,124 shares of the company were exchanged, compared to its average volume of 175,714. Cibus has a fifty-two week low of $1.40 and a fifty-two week high of $19.56. The firm has a market capitalization of $70.63 million, a price-to-earnings ratio of -0.10 and a beta of 1.70. The stock has a fifty day moving average price of $1.98 and a 200-day moving average price of $2.83.
Wall Street Analysts Forecast Growth
CBUS has been the topic of several research analyst reports. Canaccord Genuity Group lowered their price target on Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Wednesday, January 22nd. HC Wainwright reaffirmed a "buy" rating and set a $25.00 target price on shares of Cibus in a report on Friday, March 21st.
View Our Latest Analysis on CBUS
Institutional Inflows and Outflows
An institutional investor recently raised its stake in Cibus stock. Bank of America Corp DE lifted its position in Cibus, Inc. (NASDAQ:CBUS - Free Report) by 113.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,536 shares of the company's stock after acquiring an additional 18,885 shares during the quarter. Bank of America Corp DE owned approximately 0.13% of Cibus worth $99,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 33.81% of the company's stock.
Cibus Company Profile
(
Get Free Report)
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.